Corpus Intelligence IC Memo — NEWPORT MEDICAL CENTER 2026-04-26 14:11 UTC
IC Memo — NEWPORT MEDICAL CENTER
Investment Committee Memorandum | TN | 32 beds | Grade C | EBITDA uplift $3.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

NEWPORT MEDICAL CENTER

CCN 440153 | COCKE, TN | 32 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

NEWPORT MEDICAL CENTER is a 32-bed suburban community hospital in COCKE, TN with $47.8M in net patient revenue and a 11.6% operating margin. The hospital serves a payer mix of 20.4% Medicare, 2.0% Medicaid, and 77.5% commercial.

Thesis: Turnaround. Our ML models identify $3.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 11.6% to 18.9% (+736bps).

Net Revenue HCRIS$47.8M
Current EBITDA COMPUTED$5.5M
Operating Margin COMPUTED11.6%
Occupancy HCRIS89.3%
Revenue / Bed COMPUTED$1.5M
Net-to-Gross HCRIS14.6%
Distress Probability ML36.2%

2. Market Context & Competitive Position

141
TN Hospitals
-0.6%
State Median Margin
66
Comparable Hospitals

TN has 141 Medicare-certified hospitals with a median operating margin of -0.6%. The target's margin of 11.6% places it above the state median. Among 66 size-comparable peers (16-64 beds), the median margin is -0.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (16-64), prioritizing same-state peers. 66 hospitals in the comp set.

HospitalStateBedsRevenueMargin
NEWPORT MEDICAL CENTER (Target)TN32$47.8M11.6%
BAPTIST MEM HOSPITAL TIPTON COTN48$179.0M-5.8%
INDIAN PATH COMMUNITY HOSPITALTN35$142.8M12.0%
LECONTE MEDICAL CENTERTN60$126.3M6.4%
HENRY COUNTY MEDICAL CENTERTN43$81.7M-13.0%
THE CENTER FOR SPINAL SURGERYTN23$78.7M39.3%
JEFFERSON MEMORIAL HOSPITALTN58$61.3M12.7%
SWEETWATER HOSPITAL ASSOCIATIOTN55$56.6M-10.8%
ASCENSION ST THOMAS RIVER PARKTN56$53.9M-11.2%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.0M+210bp18mo
Cost to Collect4.5%2.5%$956K+200bp12mo
Denial Rate Reduction12.0%6.5%$946K+198bp12mo
A/R Days Reduction5200.0%3800.0%$582K+122bp9mo
Clean Claim Rate88.0%96.0%$31K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.0M
Cost to Collect
$956K
Denial Rate Reduction
$946K
A/R Days Reduction
$582K
Clean Claim Rate
$31K
Total EBITDA Uplift$3.5M
Current EBITDA$5.5M
+ RCM Uplift+$3.5M
Pro Forma EBITDA$9.0M
Current Margin11.6%
Pro Forma Margin18.9%
WC Released (1x)$1.8M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$8.5M$71.6M8.43x53.1%
Base (11x exit)10.0x11.0x$8.5M$81.6M9.59x57.2%
Bull Case9.0x11.0x$7.7M$95.9M12.54x65.8%
Bull (12x exit)9.0x12.0x$7.7M$106.9M13.97x69.5%
Bear Case11.0x10.0x$9.4M$51.3M5.48x40.6%
Bear (11x exit)11.0x11.0x$9.4M$59.4M6.36x44.8%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 66 hospitals with 16-64 beds
  • Same-state prioritization (n=67)
  • Comp margins: P25=-15.1% / P50=-0.8% / P75=8.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.